A Canadian astrophotographer's image of interstellar comet 3I/ATLAS, captured with a $500 telescope, has sparked debate ...
SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug ...
LAVAL, QC / ACCESS Newswire / November 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback